TOT BIOPHARM Announces NMPA Granted Marketing Approval for Pusintin® (TAB008, Bevacizumab Injection) in China
/PRNewswire/ -- TOT BIOPHARM International Company Limited (TOT BIOPHARM, 1875.HK) announced its self-developed Pusintin® (TAB008, bevacizumab injection) has...
Hong Kong Liu Jun National Medical Insurance Directory National Medical Products Administration International Company Limited Stock Code International Company Limited
Source: prnewswire.com